Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8453977 | Lung Cancer | 2018 | 24 Pages |
Abstract
Eribulin was highly active alone and in combination with radiation in treatment naïve SCLC lines and lines established from previously treated patients. In vivo pre-clinical studies of eribulin alone and in combination with radiation should be considered in SCLC cell lines.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Barbara A. Helfrich, Dexiang Gao, Paul A. Jr,